FDA Inspection
Kazimierz Kuliczkowski, M.D.Kazimierz Kuliczkowski, M.D. – FDA Inspection, Sep 18, 2015
Record Details
This FDA Inspection record concerns Kazimierz Kuliczkowski, M.D., with an inspection on September 18, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Kazimierz Kuliczkowski, M.D.
- Inspection Date
- September 18, 2015
- Product Type
- Biologics
View Company Profile
ID · 9c4f5349-627b-48cb-930b-ad46cb886d39
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 943959
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kazimierz Kuliczkowski, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 19, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Kazimierz Kuliczkowski, M.D.
- FDA Inspection 1092876 - 2019-05-16
- FDA Inspection 950460 - 2015-11-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.